May 17 (Reuters) - Ceapro Inc CZO.V
* Ceapro Inc reports 2017 first quarter development highlights and financial results
* Q1 revenue fell 22 percent to c$3.183 million
* Ceapro Inc qtrly earnings per share $0.00
* Revenue decrease of 22 pct in quarter was primarily due to a decrease in sales of Beta Glucan
* Ceapro Inc - as of March 31, 2017, company had cash and cash equivalents of $7.8 million as compared to $2.00 million as of March 31, 2016 Source text for Eikon: ID:nCCN6x10NY Further company coverage: CZO.V